The tissue analysis device maker, a spinout from Stanford University, has selected the Nasdaq Global Select Market for its initial public offering.

Akoya Biosciences, a US-based tissue analysis technology developer spun out of Stanford University, has filed to raise $115m in an initial public offering on the Nasdaq Global Select Market. Founded in 2015, Akoya has built a tissue analysis technology platform called Codex which allows users to analyse tissue cells and create images of more than…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.